Eur J Pediatr Surg 2009; 19(4): 241-245
DOI: 10.1055/s-0029-1216389
Original Article

© Georg Thieme Verlag KG Stuttgart · New York

Evidence for Medium Chain Triglycerides in the Treatment of Primary Intestinal Lymphangiectasia

A. P. Desai1 , B. H. Guvenc2 , R. Carachi3
  • 1Department of Pediatric Surgery, King's College Hospital, London
  • 2Department of Pediatric Surgery, Anadolu Medical Center, Kocaeli, Turkey
  • 3Section of Surgical Paediatrics, University of Glasgow, Glasgow,United Kingdom
Further Information

Publication History

received September 24, 2008

accepted after revision February 19, 2009

Publication Date:
15 May 2009 (online)

Abstract

Primary intestinal lymphangiectasia is an uncommon congenital anomaly. It is an intrinsic abnormality of the intestinal lymphatics system. Over the years, various treatment options such as diuretics, albumin transfusions and a medium chain triglycerides (MCT) diet as well as surgical options such as resection of isolated segments and peritoneal-venous shunts have been used. An MCT diet, which is a low fat, high protein diet, is increasingly used in the management of this anomaly.

Aim: The aim was to review the evidence for medium chain triglycerides as a therapeutic option in patients with primary intestinal lymphangiectasia.

Material and Methods: A literature search was performed and individual case details were extracted. We found 55 cases, of which 3 were from our own institute. The cases were divided in 2 groups: Group A (n=27) consisted of patients treated with MCT, and Group B (n=28) consisted patients not treated with MCT. Cases were analysed for symptomatic response to MCT as well as mortality.

Results: 17 of 27 cases (63%) treated with MCT had complete resolution of symptoms while only 10 of 28 (35.7%) patients in group B showed complete resolution. Mortality for Group A was 1 out of 27 (3.7%), while mortality in group B was 5 of 28 (17.85%) patients.

Conclusion: We conclude that, although an MCT diet is not completely curative in all cases, it does improve the symptoms of primary intestinal lymphangiectasia and reduces mortality. Hence it is a valid option in the paediatric age group.

References

  • 1 Warwick WJ, Holman RT, Quie PG. et al . Chylous ascites and lymphoedema.  J Dis Child. 1959;  98 317-329
  • 2 Jarnum S, Petersen VP. Protein-losing enteropathy.  Lancet. 1961;  1 417-421
  • 3 Cottom DG, London Dr, Wilson BDR. Neonatal eedema due to exudative enteropathy. Lancet. 1961;  1 327-330
  • 4 Waldmann TA, Steinfeld JL, Dutcher TF. et al . The role of the gastrointestinal system in “idiopathic hypoproteinemia”.  Gastroenterology. 1961;  41 197-200
  • 5 Waldmann TA, Schwab PJ. IgG (7 gamma globulin) metabolism in hypogammaglobulinaemia: studies in patients with defective gamma globulin synthesis, gastrointestinal protein loss, or both.  J Clin Invest. 1965;  44 1523-1533
  • 6 Browse NL, Wilson NM, Russo F. et al . Aetiology and treatment of chylous ascites.  Br J Surg. 1992;  79 1145-1150
  • 7 Fox U, Lucani G. Disorders of the intestinal lymphatic system.  Lymphology. 1993;  26 61-66
  • 8 Fonkalsrun EW. Congenital malformation of the lymphatic system.  Seminars in Pediatric Surgery. 1994;  3 62-69
  • 9 Vardy PA, Lebenthal E, Shwachman H. Intestinal lymphangiectasia: A reappraisal.  Pediatrics. 1975;  55 842-851
  • 10 Nazer HM, Abutalib H, Hugosson C. et al . Intestinal lymphangiectasia masquerading as coeliac disease.  Ann Trop Paediatr. 1991;  11 349-355
  • 11 Maya MM, Friedwald J. Intestinal lymphangiectasia: ultrasound evaluation of a case simulating appendicitis.  Abdom Imaging. 1993;  18 27-28
  • 12 Perisic VN, Kokai G. Coeliac disease and lymphangiectasia.  Arch Dis Child. 1992;  67 134-136
  • 13 Vallet HL, Holtzapple PG, Eberlein WR. et al . Noonan syndrome with intestinal lymphangiectasis.  A metabolic and anatomic study. J Pediatr. 1972;  80 269-274
  • 14 Perisic VN, Kokai G. Bleeding from duodenal lymphangiectasia.  Archives Dis Childhood. 1991;  66 153-154
  • 15 Lee WS, Boey CCM, Goh AYT. et al . Intestinal lymphangiectasia – A report of three Chinese children in Malaysia.  Singapore Med J. 1998;  39 418-41 421
  • 16 Strober W, Wochner RD, Carbone PP. et al . Intestinal lymphangiectasia: A protein-losing enteropathy with hypogammaglobulinaemia, lymphocytopenia and impaired homograft rejection.  J Clin Invest. 1967;  46 1643-1656
  • 17 O’Donnell D, Myers AM. Intestinal lymphangiectasia and protein losing enteropathy, toxic copper accumulation and hypoparathyroidism.  Aust NZ J Med. 1990;  20 167-169
  • 18 Stoelinga GBA, Van Munster PJJ, Slooff JP. Chylous Effusions into the intestine in a patient with protein-losing enteropathy.  Pediatrics. 1963;  31 1011-1018
  • 19 Mistilis SP, Skyring AP, Stephen DD. Intestinal lymphangiectasia.  Mechanism of enteric loss of plasma-protein and fat. Lancet. 1965;  1 77-79
  • 20 Waldmann TA. Protein-losing enteropathy.  Gastroenterology. 1966;  50 422-443
  • 21 Jeejeebhoy KN. Cause of hypoalbuminaemia in patients with gastrointestinal and cardiac disease.  Lancet. 1962;  1 343-348
  • 22 Browse NL, Stewart G. Lymphoedema: pathophysiology and classification.  J Cardiovasc Surg. 1985;  26 91-105
  • 23 Ores CN, Ores RO, Denning CR. et al . Hypercatabolic hypoproteinemia with lymphangiectasia of the small bowel.  Pediatrics. 1966;  69 439-448
  • 24 Heresbach D, Raoul J, Genetet N. et al . Immunological study in primary intestinal lymphangiectasia.  Digestion. 1994;  55 59-64
  • 25 Leyland FC, Fosbrooke AS, Lloyd JK. et al . Use of medium-chain triglycerides in children with malabsorption.  Arch Dis Childh. 1969;  44 170-179
  • 26 Jeffries GH, Chapman A, Sleisenger MH. Low-fat diet in intestinal lymphangiectasia.  Its effect on albumin metabolism. New Engl J Med. 1964;  270 761-766
  • 27 Mine K, Matsubayashi S, Nakai Y. et al . Intestinal lymphangiectasia markedly improved with antiplasmin therapy.  Gastroenterology. 1989;  96 1596-1599
  • 28 Takami A, Nakao S, Sugimori N. et al . Management of disseminated intra-abdominal lymphangiomatosis with protein-losing enteropathy and intestinal bleeding.  Southern Medical Journal. 1995;  88 1156-1158
  • 29 Holt PR. Dietary treatment of protein loss in intestinal lymphangiectasia.  Pediatrics. 1964;  34 629-635
  • 30 Rosen FS, Smith DH, Earle R. et al . The etiology of hypoproteinemia in a patient with chylous ascites.  Pediatrics. 1962;  30 696-706
  • 31 Levine C. Primary disorders of the lymphatic vessels – A unified concept.  J Paed Surg. 1989;  24 233-240
  • 32 Parfitt AM. Familial Neonatal hypoproteinaemia with exudative enteropathy and intestinal lymphangiectasis.  J Dis Child. 1966;  41 54-62
  • 33 Tift WL, Lloyd JK. Intestinal lymphangiectasia.  Long term results with MCT diet. Arch Dis Childh. 1975;  50 269-276
  • 34 Bereket A, Lowerheim M, Blethen SL. et al . Intestinal lymphangiectasia in a patient with autoimmune polyglandular disease type 1 and steatorrhoea.  J Clin Endocrinol Metab. 1995;  80 933-935
  • 35 Roisman I, Manny J, Fields S. et al . Intra-abdominal lymphangioma.  Br J Surg. 1989;  76 485-489
  • 36 Haddad HM, Wilkins L. Congenital abnormalities associates with gonadal aplasia.  Pediatrics. 1959;  23 885-902
  • 37 Dobbins WO. Hypo-beta-lipoparoteinemia and intestinal lymphangiectasia.  Arch Intern Med. 1968;  122 31-38
  • 38 Urioste M, Rodriguez JI, Barcia JM. et al . Persistence of Mullerian derivatives, lymphangiectasis, hepatic failure, postaxial polydactyly, renal and cranio-facial anomalies.  Am J Med Gen. 1993;  47 494-503
  • 39 Cormier-Daire V, Lyonnet S, Lehnert A. et al . Craniosynostosis and kidney malformation in a case of Hennekam Syndrome.  Am J Med Gen. 1995;  57 66-68
  • 40 Erdem G, Oran O, Kotiloglu E. et al . Intestinal lymphangiectasia in a patient with Zellweger cerebrohepatorenal syndrome.  Am J Med Gen. 1995;  58 152-154
  • 41 Weiden PL, Blaese RM, Strober W. et al . Impaired lymphocyte transformation in intestinal lymphangiectasia: evidence for at least two functionally distinct lymphocyte populations in man.  J Clin Invest. 1972;  51 1319-1325
  • 42 Murphy EA. N-Familial Lymphatic Dysplasia with Intestinal Lymphangiectasia. Clinical Delineation of Birth Defects of the Gastro-intestinal Tract including Liver and Pancreas. Baltimore: Williams and Wilkins 1972 Part XIII: 180-181
  • 43 Aoyagi K, Mitsuo I, Takashi Y. et al . Characteristic endoscopic features of intestinal lymphangiectasia: correlation with histological findings.  Hepatogastroenterology. 1997;  44 133-138
  • 44 Barnes RE, DeRidder PH. Fat absorption in patients with functional intestinal lymphangiectasia and lymphangiectic cysts.  Am J Gastroenterol. 1993;  88 887-890
  • 45 Salomons HA, Kramer P, Nikulasson S. et al . Endoscopic features of longstanding primary intestinal lymphangiectasia.  Gastrointestinal Endoscopy. 1995;  41 516-518
  • 46 Patel AS, DeRidder PH. Endoscopic appearance and significance of functional intestinal lymphangiectasia of the duodenal mucosa.  Gastrointest Endosc. 1990;  36 367-368
  • 47 Antao B, Bishop J, Shawis R. et al . Clinical application and diagnostic yield of wireless capsule endoscopy in children.  J Laparoendosc Adv Surg Tech A. 2007;  17 364-370
  • 48 Hubalewska- Hola A, Sowa- Staszczak A, Szczerbinski T. et al . Protein losing enteropathy detected by Tc99m-labelled serum albumin ab-dominal scintigraphy – case report.  Przegl Lek. 2003;  60 606-608
  • 49 Kuroiwa G, Takayama T, Sato Y. et al . Primary intestinal lymphangiectasia successfully treated with octreotide.  J Gastroenterology. 2001;  36 129-132
  • 50 Makhija S, von der Weid Py, Meddings J. et al . Octreotide in intestinal lymphangiectasia: lack of a clinical response and failure to alter lymphatic function in a guinea pig model.  Can J Gastroenterol. 2004;  18 681-685

Correspondence

Mr. A. P. DesaiMBBS, MS, MCh, DNB, FEBPS, FRCS 

Department of Pediatric Surgery

King's College Hospital

Denmark Hill

London

United Kingdom

SE5 9RS

Phone: +44/79/1059 06 80

Fax: +44/20/3299 40 21

Email: ashishdesai@doctors.org.uk